Organ-on-a-Chip systems for new drugs development

Authors

  • Ronny Vargas Industrial Pharmacy Department, Faculty of Pharmacy, University of Costa Rica 11501-2060, San José, Costa Rica https://orcid.org/0000-0001-7319-6145
  • Laura Medina Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-1, 08028, Barcelona, Spain https://orcid.org/0000-0002-5156-8515
  • Andrea Egurbide-Sifre Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-1, 08028, Barcelona, Spain https://orcid.org/0000-0003-4745-2939

DOI:

https://doi.org/10.5599/admet.942
Organ-on-a-Chip

Abstract

Research on alternatives to the use of animal models and cell cultures has led to the creation of organ-on-a-chip systems, in which organs and their physiological reactions to the presence of external stimuli are simulated. These systems could even replace the use of human beings as subjects for the study of drugs in clinical phases and have an impact on personalized therapies. Organ-on-a-chip technology present higher potential than traditional cell cultures for an appropriate prediction of functional impairments, appearance of adverse effects, the pharmacokinetic and toxicological profile and the efficacy of a drug. This potential is given by the possibility of placing different cell lines in a three-dimensional-arranged polymer piece and simulating and controlling specific conditions. Thus, the normal functioning of an organ, tissue, barrier, or physiological phenomenon can be simulated, as well as the interrelation between different systems. Furthermore, this alternative allows the study of physiological and pathophysiological processes. Its design combines different disciplines such as materials engineering, cell cultures, microfluidics and physiology, among others. This work presents the main considerations of OoC systems, the materials, methods and cell lines used for their design, and the conditions required for their proper functioning. Examples of applications and main challenges for the development of more robust systems are shown. This non-systematic review is intended to be a reference framework that facilitates research focused on the development of new OoC systems, as well as their use as alternatives in pharmacological, pharmacokinetic and toxicological studies.

Downloads

Download data is not yet available.

Downloads

Published

20-03-2021

How to Cite

Vargas, R., Medina, L., & Egurbide, A. (2021). Organ-on-a-Chip systems for new drugs development. ADMET and DMPK, 9(2), 111–141. https://doi.org/10.5599/admet.942

Issue

Section

Reviews